TABLE 1.
Clinical parameters | Patients (N = 77) |
Age (years) | 60.3 (40∼78) |
Gender | |
Male | 56 (72.7%) |
Female | 21 (27.3%) |
BMI (kg/m2) | 23.4 |
Smoking history | |
Never smoker | 49 (63.6%) |
Ever smoker | 28 (36.4%) |
Tumor position | |
Central | 23 (29.9%) |
Peripheral | 54 (70.1%) |
Pathology | |
Lung adenocarcinoma | 40 (51.9%) |
Lung squamous carcinoma | 30 (39.0%) |
Others | 7 (9.1%) |
Tumor stage | |
Stage I | 40 (51.9%) |
Stage II | 18 (23.4%) |
Stage III | 17 (22.1%) |
Stage IV | 2 (2.6%) |
Lobe | |
Right-upper | 26 (33.8%) |
Right-middle | 2 (2.6%) |
Right-lower | 18 (23.3%) |
Left-upper | 20 (26.0%) |
Left-lower | 11 (14.3%) |
Data are given as N (percentage) unless otherwise indicated. N, number; BMI, body mass index.